GlassScriptPhysician profile
Arshad Mahmood
NPI 1508811696
$10,754.60
in general payments reported to CMS, 2019-2025
47 companies · $1,067 in 2025
The $1,067 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,595 · 2020: $1,014 · 2021: $1,463 · 2022: $1,250 · 2023: $1,944 · 2024: $1,422 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,364 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,363.85 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,558.33 | 2019-2025 | Farxiga, Andexxa, Lokelma |
| Janssen Pharmaceuticals, INC | $1,436.80 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $989.25 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $758.50 | 2019-2025 | |
| Amgen INC. | $735.87 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $624.28 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $582.08 | 2019-2025 | Lifevest |
| Pfizer INC. | $416.97 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $318.50 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.67 | 2021-2025 | |
| Heartflow, INC. | $290.43 | 2022-2025 | Ffrct |
| Boston Scientific Corporation | $240.41 | 2019-2025 | Watchman |
| Medtronic, INC. | $230.09 | 2022-2024 | Resolute Onyx, Symplicity G3 |
| Actelion Pharmaceuticals US, INC. | $226.40 | 2019-2024 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $202.99 | 2019-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $192.08 | 2022-2023 | Assure Wcd |
| Abbott Laboratories | $151.13 | 2019-2025 | Viewmate, Aveir |
| Esperion Therapeutics, INC. | $131.16 | 2020-2025 | Nexletol |
| Daiichi Sankyo INC. | $124.69 | 2023-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $121.63 | 2021-2023 | Verquvo |
| Scpharmaceuticals INC. | $108.86 | 2023-2025 | |
| Novo Nordisk INC | $105.41 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $101.85 | 2020-2025 | Onpattro |
| Lundbeck LLC | $92.01 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $69.18 | 2023 | Inpefa |
| Cvrx, INC. | $51.91 | 2021-2023 | Barostim Neo System |
| Lilly USA, LLC | $51.75 | 2025 | Mounjaro, Zepbound |
| Atricure, INC. | $45.84 | 2020-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $45.42 | 2023 | Arcalyst |
| Stryker Corporation | $45.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kiniksa Pharmaceuticals International, Plc | $45.03 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $39.62 | 2019 | |
| Vifor Pharma, INC. | $34.95 | 2021 | |
| Portola Pharmaceuticals, LLC | $31.31 | 2019 | |
| Tactile Systems Technology INC | $28.85 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Gilead Sciences, INC. | $24.98 | 2019 | |
| Teleflex LLC | $23.51 | 2023 | Arrow |
| Inari Medical, INC. | $23.26 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $21.64 | 2025 | Cardiva Vascade 6/7f Vcs |
| Resmed Corp | $19.31 | 2020 | |
| Edwards Lifesciences Corporation | $18.84 | 2022 | |
| Preventice Services, LLC | $18.63 | 2021 | |
| Abiomed | $17.58 | 2023 | Impella |
| United Therapeutics Corporation | $15.96 | 2023 | Tyvaso |
| Akcea Therapeutics, INC. | $13.37 | 2019 | |
| Baxter Healthcare | $13.37 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.